
Contact us
About company
ARC Therapeutics is developing selective CDK inhibitors for patients living with advanced and resistant forms of cancer.
US 600 park office drive
Unknown
Not verified company
ARC Therapeutics is developing selective CDK inhibitors for patients living with advanced and resistant forms of cancer.